Seen in the press: Novelia® eyedropper on Ophthalmic OnDrug DeliveryJanuary 30, 2018
Seen in the press: Novelia® eyedropper on Ophthalmic Drug Delivery magazine
The recently published Ophthalmic Drug Delivery Magazine, which is focused on ophthalmic technologies, shows our eyedropper Novelia on the cover and illustrates it in an article.
On page 16, you can find an interview with Fanny Sellier (Global Category Manager for Ophthalmic range). She presents Nemera’s multidose eyedropper system Novelia® for preservative-free formulations, explaining how this platform has been developed to improve patients’ lives.
“One of the most significant factors driving the ophthalmic market today
is adherence to treatment.”
For more information on our Novelia® and ophthalmic expertise, meet us at Pharmapack, which will take place in Paris, on 7-8 February.
The full article:
The full issue of the magazine:
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.